PMA

P000029: DEFLUX INJECTABLE GEL

FDA PMA · AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE · Palette Life Sciences

Key facts

PMA number P000029
Trade name DEFLUX INJECTABLE GEL
Generic name AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant Palette Life Sciences
Owner/operator Palette Life Sciences
Product code LNM
Approval date Sep 24, 2001
Docket number 01M-0439
Notice date Oct 1, 2001
Establishment registration 3014909464
FEI number 3014909464

At a glance

  • 10–99 Supplements
  • May 31, 2024 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals